Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 7/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14843728 | 0.89 | RIPK1 (0.30) | RIPK1 | |
| SCHEMBL30478441 | 0.88 | ALDH1A1 (0.32) | RIPK1CYP2C19HIF1AALDH1A1ALOX15 | |
| SCHEMBL2707979 | 0.87 | ALDH1A1 (0.43) | ALDH1A1CNR2CHRM2MAPTKMT2A | |
| SCHEMBL786199 | 0.86 | ALDH1A1 (0.45) | ALDH1A1CNR2CHRM2MAPTKMT2A | |
| SCHEMBL38652251 | 0.86 | MAPK1 (0.32) | ALDH1A1ALOX15 | |
| SCHEMBL9721468 | 0.86 | SCN1A (0.33) | CYP2C19CHRM2CHRM1CHRM3CHRM4 | |
| SCHEMBL29614441 | 0.82 | PPARG (0.36) | ALDH1A1KMT2A | |
| SCHEMBL29849003 | 0.82 | PPARG (0.34) | — | |
| SCHEMBL855518 | 0.81 | CYP2C19 (0.40) | CYP2C19HIF1AALDH1A1ALOX15KIF11 | |
| SCHEMBL168362 | 0.77 | ACACB (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577340-B2 | Storage stable two-component dual cure dental composition | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-17 | — | — | US | claimed |
| US-20250353967-A1 | CURABLE SILOXANE RESIN COMPOSITION AND FILM INCLUDING THE SAME | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-11-20 | — | — | US | claimed |
| US-12331164-B2 | Curable siloxane resin composition | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-06-17 | — | — | US | claimed |
| EP-4103548-B1 | COMPOSITION COMPRISING AT LEAST ONE ORGANIC PEROXIDE, AT LEAST ONE EMULSIFIER, AND HYDROGEN PEROXIDE | ARKEMA FRANCE (FR) | 2023-11-08 | — | — | EP | claimed |
| US-20230078587-A1 | CURABLE SILOXANE RESIN COMPOSITION | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-03-16 | — | — | US | claimed |
| EP-3677604-B1 | METHOD FOR PREPARING ETHYLENE VINYLACETATE COPOLYMER | LG CHEMICAL LTD (KR) | 2023-03-08 | — | — | EP | claimed |
| EP-3710503-B1 | FUNCTIONALIZED POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2022-01-05 | — | — | EP | claimed |
| EP-3715387-B1 | VINYL CHLORIDE-BASED POLYMER AND PREPARATION METHOD THEREOF | LG CHEMICAL LTD (KR) | 2022-01-05 | — | — | EP | claimed |
| US-20210403701-A1 | CURABLE RESIN COMPOSITION, AND FILM, MOLDED ARTICLE, PREPREG, AND FIBER-REINFORCED PLASTIC USING SAID CURABLE RESIN COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | claimed |
| EP-2970538-B1 | POLYMERIZATION PROCESS PROTECTION MEANS | DUPONT ELECTRONICS INC (US) | 2021-10-20 | — | — | EP | claimed |
| EP-0572115-B1 | Process for preparing crosslinked methacrylic anhydride copolymers | ROHM & HAAS (US) | 1998-03-04 | — | — | EP | claimed |
| EP-0823443-A2 | Foamed particles of modified polypropylene resin and method of preparing same | JSP CORPORATION (JP) | 1998-02-11 | — | — | EP | claimed |
| EP-0659194-B1 | PROCESS FOR (CO)POLYMERIZING VINYL MONOMERS | KAYAKU NOURY CORP (JP) | 1996-10-09 | — | — | EP | claimed |
| EP-0682043-A2 | Processes for preparing vinyl chloride polymers | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1995-11-15 | — | — | EP | claimed |
| EP-0309088-B1 | In-mold coating powder containing 1,1'-di(t-butylperoxy)-3,3,5-trimethylcyclohexane as an initiator. | MORTON INT INC (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0134388-B1 | PROCESS FOR PRODUCING A BLOW MOLDING RESIN | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-07-14 | — | — | EP | claimed |
| US-4873274-A | In-mold coating powders with two initiators or 1,1-di(t-butylperoxy)-3,3,5-trimethylcyclohexane as a single initiator | MORTON THIOKOL, INC. (US) | 1989-10-10 | — | — | US | claimed |
| EP-0191875-B1 | PROCESS FOR PREPARATION OF POLYVINYL CHLORIDE TYPE POLYMER | Tosoh Corporation (JP) | 1989-04-19 | — | — | EP | claimed |
| EP-0309088-A2 | In-mold coating powder containing 1,1'-di(t-butylperoxy)-3,3,5-trimethylcyclohexane as an initiator. | MORTON INTERNATIONAL, INC. (US) | 1989-03-29 | — | — | EP | claimed |
| EP-0090627-B1 | METHOD FOR PRODUCING A PLASTIC LENS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1987-05-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577340-B2 | Storage stable two-component dual cure dental composition | GPX4, SSRP1, H1-0 | RIPK1 4022/4885CYP2C19 3365/4885HIF1A 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.